Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A new brain‐penetrant glucosylceramide synthase inhibitor as potential Therapeutics for Gaucher disease
Takahiro Fujii, Yuta Tanaka, Hideyuki Oki, et al.
Journal of Neurochemistry (2021) Vol. 159, Iss. 3, pp. 543-553
Open Access | Times Cited: 16

Showing 16 citing articles:

Late-stage Functionalization for Improving Drug-like Molecular Properties
Nathan J. Castellino, Andrew P. Montgomery, Jonathan J. Danon, et al.
Chemical Reviews (2023) Vol. 123, Iss. 13, pp. 8127-8153
Closed Access | Times Cited: 98
Mysterious sphingolipids: metabolic interrelationships at the center of pathophysiology
Rama Jamjoum, Saurav Majumder, Batoul M. Issleny, et al.
Frontiers in Physiology (2024) Vol. 14
Open Access | Times Cited: 13
Targeting the Sphingolipid Rheostat in Gliomas
Faris Zaibaq, Tyrone Dowdy, Mioara Larion
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9255-9255
Open Access | Times Cited: 22
Discovery of Brain-Penetrant Glucosylceramide Synthase Inhibitors with a Novel Pharmacophore
Y. Tanaka, Masaki Seto, Keiko Kakegawa, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 5, pp. 4270-4290
Open Access | Times Cited: 11
A PIKfyve modulator combined with an integrated stress response inhibitor to treat lysosomal storage diseases
William C. Hou, Lynée A. Massey, Derek Rhoades, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 34
Open Access | Times Cited: 2
Newborn screening for Gaucher disease in Japan
Takaaki Sawada, Jun Kido, Keishin Sugawara, et al.
Molecular Genetics and Metabolism Reports (2022) Vol. 31, pp. 100850-100850
Open Access | Times Cited: 10
Gaucher Disease: A Glance from a Medicinal Chemistry Perspective
Filippo Prencipe, Chiara Barzan, Chiara Savian, et al.
ChemMedChem (2024) Vol. 19, Iss. 10
Closed Access | Times Cited: 1
Juvenile mucopolysaccharidosis plus disease caused by a missense mutation in VPS33A
Elena Pavlova, Dorit Lev, Marina Michelson, et al.
Human Mutation (2022) Vol. 43, Iss. 12, pp. 2265-2278
Open Access | Times Cited: 7
Metabolomic Study Using Time-of-Flight Mass Spectrometry Reveals Novel Urinary Biomarkers for Gaucher Disease Type 1
Iskren Menkovic, Michel Boutin, Abdulfatah Alayoubi, et al.
Journal of Proteome Research (2022) Vol. 21, Iss. 5, pp. 1321-1329
Closed Access | Times Cited: 5
In situ glucosylceramide synthesis and its pharmacological inhibition analysed in cells by 13C5‐sphingosine precursor feeding and mass spectrometry
Rebecca E. Katzy, Maria J. Ferraz, Marc Hazeu, et al.
FEBS Letters (2022) Vol. 596, Iss. 18, pp. 2400-2408
Open Access | Times Cited: 3
Photoredox-based late-stage functionalization in SAR study for in vivo potent glucosylceramide synthase inhibitor
Junsi Wang, Matthew R. Reynolds, Ignacio González-Varas Ibáñez, et al.
Bioorganic & Medicinal Chemistry Letters (2022) Vol. 77, pp. 129039-129039
Closed Access | Times Cited: 3
Glycosphingolipids and central nervous system–related diseases
Zhongwu Guo
Elsevier eBooks (2024), pp. 243-351
Closed Access
A sensitive method for determining UDP-glucose: ceramide glucosyltransferase (UGCG) activity in biological samples using deuterated glucosylceramide as acceptor substrate
Michele Dei, Sara Casati, Gabriella Roda, et al.
Glycobiology (2022) Vol. 33, Iss. 2, pp. 88-94
Open Access | Times Cited: 2
Drug Development in the Field of Sphinogolipid Metabolism
Zhibei Qu, Lu Zhou
Advances in experimental medicine and biology (2022), pp. 169-188
Closed Access
Juvenile Mucopolysaccharidosis plus disease caused by a missense mutation inVPS33A
Elena Pavlova, Dorit Lev, Marina Michelson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top